---
figid: PMC6487791__mjy072f02
figlink: /pmc/articles/PMC6487791/figure/mjy072F2/
number: Figure 2
caption: Representative working modes of mutant p53 GOF. (A) p53-R249S is phosphorylated
  by CDK4/cyclin D1 and translocated into the nucleus as mediated by PIN1. The nuclear
  R249S binds to and augments c-Myc activity, leading to enhanced ribosome biogenesis
  and proliferation. (B) Mutant p53 prompts TGF-β-mediated EMT and metastasis by binding
  to Smad2/3. The interaction between mutant p53 and Smads leads to elevation of the
  downstream EMT and metastasis genes. Also, mutant p53, Smads, and TAp63 form a ternary
  complex that suppresses the anti-metastasis activity of TAp63. (C) Mutant p53 interferes
  with the assembly of the Mre11–Rad50–NBS1 complex on DNA double-stranded breaks,
  leading to genome instability. (D) Mutant p53 transcriptionally induces RhoGD1 and
  RhoGEF-H1 (; ) through mechanisms to be identified, which elicits RhoA–ROCK–GLUT1
  cascade, leading to increased aerobic glycolysis. Additionally, mutant p53 binds
  to the transcription factor SREBP, leading to the activated mevalonate pathway responsible
  for the regulation of lipid metabolism. (E) Mutant p53 modulates redox and proteasome
  by interacting with NRF2. Mutant p53 can induce and repress NRF2 target genes to
  control the glutathione (GSH) level and the redox balance. Moreover, mutant p53
  promotes the expression of NRF2 target genes involved in proteasome machinery, leading
  to increased proteasomal degradation of tumor suppressors. (F) Mutant p53 suppresses
  apoptosis by directly binding to caspases. Upon external and/or internal stimuli,
  the initiator caspases, caspase-8, and caspase-9, can proteolytically activate the
  effector caspases, caspase-3, caspase-6, and caspase-7, thus triggering the caspase-dependent
  apoptosis. However, mutant p53 can interact with and inhibit caspase-8, caspase-9,
  and caspase-3 to compromise the caspase-dependent apoptosis. In conclusion, p53
  mutants execute their oncogenic GOF by interacting with transcription factors or
  cofactors to promote (A, B, D, E) or repress (B, E) gene expression, or with proteins
  irrelevant to transcription (C, F). mtp53 indicates mutant p53.
pmcid: PMC6487791
papertitle: Mutant p53 in cancer therapy—the barrier or the path.
reftext: Xiang Zhou, et al. J Mol Cell Biol. 2019 Apr;11(4):293-305.
pmc_ranked_result_index: '229564'
pathway_score: 0.8641285
filename: mjy072f02.jpg
figtitle: Representative working modes of mutant p53 GOF
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6487791__mjy072f02.html
  '@type': Dataset
  description: Representative working modes of mutant p53 GOF. (A) p53-R249S is phosphorylated
    by CDK4/cyclin D1 and translocated into the nucleus as mediated by PIN1. The nuclear
    R249S binds to and augments c-Myc activity, leading to enhanced ribosome biogenesis
    and proliferation. (B) Mutant p53 prompts TGF-β-mediated EMT and metastasis by
    binding to Smad2/3. The interaction between mutant p53 and Smads leads to elevation
    of the downstream EMT and metastasis genes. Also, mutant p53, Smads, and TAp63
    form a ternary complex that suppresses the anti-metastasis activity of TAp63.
    (C) Mutant p53 interferes with the assembly of the Mre11–Rad50–NBS1 complex on
    DNA double-stranded breaks, leading to genome instability. (D) Mutant p53 transcriptionally
    induces RhoGD1 and RhoGEF-H1 (; ) through mechanisms to be identified, which elicits
    RhoA–ROCK–GLUT1 cascade, leading to increased aerobic glycolysis. Additionally,
    mutant p53 binds to the transcription factor SREBP, leading to the activated mevalonate
    pathway responsible for the regulation of lipid metabolism. (E) Mutant p53 modulates
    redox and proteasome by interacting with NRF2. Mutant p53 can induce and repress
    NRF2 target genes to control the glutathione (GSH) level and the redox balance.
    Moreover, mutant p53 promotes the expression of NRF2 target genes involved in
    proteasome machinery, leading to increased proteasomal degradation of tumor suppressors.
    (F) Mutant p53 suppresses apoptosis by directly binding to caspases. Upon external
    and/or internal stimuli, the initiator caspases, caspase-8, and caspase-9, can
    proteolytically activate the effector caspases, caspase-3, caspase-6, and caspase-7,
    thus triggering the caspase-dependent apoptosis. However, mutant p53 can interact
    with and inhibit caspase-8, caspase-9, and caspase-3 to compromise the caspase-dependent
    apoptosis. In conclusion, p53 mutants execute their oncogenic GOF by interacting
    with transcription factors or cofactors to promote (A, B, D, E) or repress (B,
    E) gene expression, or with proteins irrelevant to transcription (C, F). mtp53
    indicates mutant p53.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIN1
  - NLRP2
  - RAD50
  - CASP5
  - CASP2
  - CASP3
  - CASP4
  - CASP9
  - CASP6
  - CASP7
  - CASP8
  - MRE11
  - ROCK2
  - SLC7A11
  - SMAD2
  - SMAD3
  - SNAI1
  - RHOA
  - ARHGDIA
  - ARHGDIB
  - ARHGDIG
  - CDK4
  - MYC
  - SLC2A1
  - CASP12
  - CASP14
  - CASP1
  - TAAR9
  - TGFB1
  - TGFB2
  - SNAI2
  - TGFB3
  - TXN
  - CASP10
  - ROCK1
  - Mevalonate
  - GSH
  - AOS
genes:
- word: PIN1
  symbol: PIN1
  source: hgnc_symbol
  hgnc_symbol: PIN1
  entrez: '5300'
- word: NBS1
  symbol: NBS1
  source: hgnc_alias_symbol
  hgnc_symbol: NLRP2
  entrez: '55655'
- word: Rad50
  symbol: RAD50
  source: hgnc_symbol
  hgnc_symbol: RAD50
  entrez: '10111'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Mre11
  symbol: MRE11
  source: hgnc_symbol
  hgnc_symbol: MRE11
  entrez: '4361'
- word: ROCK
  symbol: ROCK
  source: bioentities_symbol
  hgnc_symbol: ROCK2
  entrez: '9475'
- word: SLC7A11
  symbol: SLC7A11
  source: hgnc_symbol
  hgnc_symbol: SLC7A11
  entrez: '23657'
- word: Smad2/3
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: Smad2/3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: Snail1/2
  symbol: SNAIL1
  source: hgnc_alias_symbol
  hgnc_symbol: SNAI1
  entrez: '6615'
- word: RhoA
  symbol: RhoA
  source: hgnc_alias_symbol
  hgnc_symbol: RHOA
  entrez: '387'
- word: RhoGDI
  symbol: RhoGDI
  source: bioentities_symbol
  hgnc_symbol: ARHGDIA
  entrez: '396'
- word: RhoGDI
  symbol: RhoGDI
  source: bioentities_symbol
  hgnc_symbol: ARHGDIB
  entrez: '397'
- word: RhoGDI
  symbol: RhoGDI
  source: bioentities_symbol
  hgnc_symbol: ARHGDIG
  entrez: '398'
- word: CDK4
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: C-MYC
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: GLUT1
  symbol: GLUT1
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A1
  entrez: '6513'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: TAрб3
  symbol: TA3
  source: hgnc_alias_symbol
  hgnc_symbol: TAAR9
  entrez: '134860'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: Snail1/2
  symbol: SNAIL2
  source: hgnc_alias_symbol
  hgnc_symbol: SNAI2
  entrez: '6591'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: TXN
  symbol: TXN
  source: hgnc_symbol
  hgnc_symbol: TXN
  entrez: '7295'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: ROCK
  symbol: ROCK
  source: bioentities_symbol
  hgnc_symbol: ROCK1
  entrez: '6093'
chemicals:
- word: Mevalonate
  source: MESH
  identifier: D008798
- word: GSH
  source: MESH
  identifier: D005978
diseases:
- word: AOS
  source: MESH
  identifier: C538225
---
